Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,133-18,144 of 23,847
Behavioral study icon
CompletedNCT05963581

Oxford Social Movement Activation Study

This summary needs review. Please check the official study record and contact the research team for details.

In Oxford
DepressionBehavioralFrom 18 Years to 24 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Behavioral study icon
CompletedNCT06136390

OXYMIND: Oxytocin-augmented Group Psychotherapy for people with Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Berlin
SchizophreniaBehavioralFrom 18 Years to 75 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
Drug study icon
TerminatedNCT00506909

Oxytocin Add on Study for Stable Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
David Feifel
Condition
Schizophrenia
Drug study icon
CompletedNCT02671266

Oxytocin Administration in BDD and OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
OCDDrugOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
OCD
Drug study icon
CompletedNCT02546570

Oxytocin and Affect Processing in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
PTSDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
PTSD
Drug study icon
TerminatedNCT02979093

Oxytocin and Brain Responses in Maternal Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
AddictionDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
Lane Strathearn, MBBS PhD
Condition
Addiction
Drug study icon
CompletedNCT01752712

Oxytocin and CBSST for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT03136263

Oxytocin and Cognitive Control in Adult ADHD

This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In Boston
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
OngoingEUCTR 2022-000603-12

Oxytocin and reactivity to infant signals in mothers with postpartum depression

This study is comparing Syntocinon Nasal Spray with placebo for people with We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression. Participants receive Syntocinon Nasal Spray or placebo and complete study visits and assessments.

In Netherlands
DepressionOther
Countries
Netherlands
Sponsor
Radboud University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.